Pricing Log in Create free account

Cibus, Inc. (CBUS) vs vTv Therapeutics Inc. (VTVT)

Cibus, Inc. and vTv Therapeutics Inc. are both Biotechnology companies. Cibus, Inc. and vTv Therapeutics Inc. are of similar size ($95.0M and $94.8M). vTv Therapeutics Inc. grew revenue faster over the last twelve months: 654.6% against −10.3%. vTv Therapeutics Inc. has the higher net margin (0.00% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, vTv Therapeutics Inc. leads on 13 and Cibus, Inc. on 4.

Valuation

Metric CBUS VTVT Biotechnology median
P/E n/m n/m 10.26
P/S 20.48 7.15 9.18
P/B 6.02 3.44 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 16.03 4.90 8.98
Earnings yield (142.24%) (3.53%) (34.89%)
Free cash flow yield (51.98%) (6.23%) (24.52%)

Profitability

Metric CBUS VTVT Biotechnology median
Gross margin 100.00% 99.92% 65.16%
Operating margin (1,450.59%) 0.00% 0.00%
Net margin (2,258.89%) 0.00% 0.00%
Free cash flow margin (1,064.60%) 0.00% 0.00%
Return on equity (219.97%) (11.74%) (50.12%)
Return on assets (29.77%) (8.34%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBUS VTVT Biotechnology median
Revenue growth (TTM) (10.30%) 654.58% 6.26%
EPS growth (last fiscal year) 74.33% 0.00% 29.88%
Revenue growth, 5-year CAGR (31.34%) (39.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBUS VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.62 12.48 4.89
Net debt to EBITDA (0.28) 2.71 1.01

Dividend

Metric CBUS VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CBUS VTVT Biotechnology median
Market cap 94.77m 95.02m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack